title: [Pain management in Stevens-Johnson syndrome, toxic epidermal necrolysis and other blistering diseases].
authors: Département de dermatologie, centre de référence des maladies bulleuses immunologiques et toxiques, hôpital Henri-Mondor, AP-HP, université Paris XII, UPEC, Créteil, France. laurence.allanore@hmn.aphp.fr
authors: L
authors: L
authors: Valeyrie-Allanore
authors: S
authors: S
authors: Ingen-Housz-Oro
authors: A
authors: A
authors: Colin
authors: D
authors: D
authors: Thuillot
authors: M-L
authors: ML
authors: Sigal
authors: M
authors: M
authors: Binhas
mesh_terms: D000700:Analgesics / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D019468:Disease Management; D004359:Drug Therapy, Combination; D058447:Eye Pain / Q000209:etiology / Q000628:therapy; D006801:Humans; D007441:Intubation, Gastrointestinal; D009609:Nitrous Oxide / Q000627:therapeutic use; D009779:Occlusive Dressings; D009883:Ophthalmic Solutions / Q000627:therapeutic use; D010100:Oxygen / Q000627:therapeutic use; D010146:Pain / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D059408:Pain Management; D010147:Pain Measurement; D012872:Skin Diseases, Vesiculobullous / Q000150:complications* / Q000628:therapy; D013262:Stevens-Johnson Syndrome / Q000150:complications* / Q000628:therapy; D014014:Tissue Adhesives
chemical_list: D000700:Analgesics; D014151:Anti-Anxiety Agents; D009883:Ophthalmic Solutions; D014014:Tissue Adhesives; C001147:Entonox; D009609:Nitrous Oxide; D010100:Oxygen